An LNP-mRNA vaccine provides potent immunogenicity and protection against Mycobacterium tuberculosis
Hannah Lukeman, Hareth A. Al-Wassiti, Stewart A. Fabb, Leonard Lim, Trixie Wang, Warwick J. Britton, Megan C. Steain, Colin William Pouton, James A. Triccas, Claudio Counoupas
This study develops an LNP-mRNA vaccine against Mycobacterium tuberculosis that induces strong immune responses and protects mice from infection, with potential for human application.
EBioMedicine · Feb 15, 2025Peer-reviewedImmunology